Walleye Trading
CVAC

Walleye Trading’s CureVac CVAC Stock Holding History

Walleye Trading’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,032
Closed -$114K – 4859
2023
Q4 		$114K Buy
27,032
+8,366
+45% +$45.4K ﹤0.01% 4091
2023
Q3 		$127K Buy
18,666
+10,687
+134% +$94.4K ﹤0.01% 3853
2023
Q2 		$83.1K Buy
+7,979
New +$71.4K ﹤0.01% 3814
2022
Q2 		– Sell
-594
Closed -$9.83K – 5213
2022
Q1 		$12K Sell
594
-1,000
-63% -$20K ﹤0.01% 4895
2021
Q4 		$55K Sell
1,594
-6,229
-80% -$251K ﹤0.01% 4638
2021
Q3 		$427K Buy
+7,823
New +$471K ﹤0.01% 3079

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Walleye Trading's CVAC Position: Q1 2024 in Review

Walleye Trading sold out of CureVac (CVAC) in Q1 2024, closing a stake of 27,032 shares — an estimated $114K sold.

Walleye Trading first reported a position in CVAC in Q3 2021 and held it in 6 quarters. The position peaked at $427K in Q3 2021. 90 funds tracked by Wall St. Rank hold CVAC as of Q1 2024.

  • Walleye Trading reported no remaining CureVac position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 27,032 CureVac shares in Q1 2024, an estimated $114K.
  • Walleye Trading first reported a position in CureVac in Q3 2021 and held it in 6 quarters.
  • Walleye Trading's CureVac position peaked at $427K in Q3 2021.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.